Astringent (TAGI Pharma Inc.)


Welcome to the PulseAid listing for the Astringent drug offered from TAGI Pharma Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: TAGI Pharma Inc.
NON-PROPRIETARY NAME: Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate
SUBSTANCE NAME: CALCIUM ACETATE MONOHYDRATE; ALUMINUM SULFATE TETRADECAHYDRATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00


Astringent HUMAN OTC DRUG Details:

Item DescriptionAstringent from TAGI Pharma Inc.
LABELER NAME: TAGI Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 952; 1347(mg/2299mg; mg/2299mg)
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51224-162_3df1c75d-2a03-48b1-9943-4d6ca9929fa2
PRODUCT NDC: 51224-162
APPLICATION NUMBER: part347

Other CALCIUM ACETATE MONOHYDRATE; ALUMINUM SULFATE TETRADECAHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
TAGI Pharma Inc.Astringent